Resmed (RMD) Research & Development (2016 - 2025)
Historic Research & Development for Resmed (RMD) over the last 17 years, with Q4 2025 value amounting to $91.0 million.
- Resmed's Research & Development rose 1179.4% to $91.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $348.7 million, marking a year-over-year increase of 936.2%. This contributed to the annual value of $331.3 million for FY2025, which is 772.59% up from last year.
- Per Resmed's latest filing, its Research & Development stood at $91.0 million for Q4 2025, which was up 1179.4% from $87.3 million recorded in Q3 2025.
- Resmed's Research & Development's 5-year high stood at $91.0 million during Q4 2025, with a 5-year trough of $55.9 million in Q1 2021.
- Its 5-year average for Research & Development is $73.7 million, with a median of $76.1 million in 2023.
- Its Research & Development has fluctuated over the past 5 years, first soared by 2149.82% in 2023, then soared by 83.47% in 2024.
- Quarter analysis of 5 years shows Resmed's Research & Development stood at $62.5 million in 2021, then grew by 11.79% to $69.9 million in 2022, then rose by 5.73% to $73.9 million in 2023, then rose by 10.14% to $81.4 million in 2024, then grew by 11.79% to $91.0 million in 2025.
- Its Research & Development stands at $91.0 million for Q4 2025, versus $87.3 million for Q3 2025 and $86.4 million for Q2 2025.